Literature DB >> 9720802

B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects.

L Morbidelli1, A Parenti, L Giovannelli, H J Granger, F Ledda, M Ziche.   

Abstract

1. Bradykinin (BK) contributes to the inflammatory response inducing vasodilation of postcapillary venules and has been demonstrated to induce neovascular growth in subcutaneous rat sponges. 2. In this study the ability of BK to stimulate cell growth and migration in cultured endothelium from coronary postcapillary venules (CVEC) has been investigated. 3. [3H]-thymidine incorporation in subconfluent and synchronised CVEC was used to monitor DNA synthesis over 24 h. BK promoted a concentration-dependent increase of DNA synthesis with maximal activity at 100 nM. At this concentration BK also induced 18 fold accumulation of c-Fos protein immunoreactivity in the nucleus within 1 h from peptide exposure. 4. The total number of cells recovered after 48 h exposure to BK was increased in a concentration-dependent manner. Maximal effect was produced by 100 nM concentration of the peptide which produced 50% increase in cell number. The selective B1 receptor agonist Des-Arg9-BK mimicked the proliferative effect of BK, while the B2 receptor agonist kallidin was devoid of any activity. The proliferation induced by BK was abolished in a concentration-dependent manner by the addition of the B1 selective antagonist Des-Arg9-Leu8-BK, while the selective B2 receptor antagonist HOE140 did not modify BK-induced growth. 5. DNA synthesis and growth promoted by a threshold concentration of fibroblast growth factor-2 (FGF-2) (0.25 nM) were potentiated by increasing concentrations of BK and Des-Arg9-BK. 6. Endothelial cell migration assessed by the Boyden Chamber procedure was not promoted by BK or the selective B1 and B2 receptor agonists. 7. These data are the first demonstration that BK promotes growth of endothelial cells from postcapillary venules. The mitogenic activity of BK involves c-Fos expression and potentiates the growth promoting effect of FGF-2. Only the B1 receptor appears to be responsible for the proliferation induced by BK and suggests that this type of receptor might be implicated in favouring angiogenesis of coronary venules.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9720802      PMCID: PMC1565498          DOI: 10.1038/sj.bjp.0701943

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

Review 1.  Nitric oxide and angiogenesis.

Authors:  M Ziche; L Morbidelli
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

2.  A synthetic tissue kallikrein inhibitor suppresses cancer cell invasiveness.

Authors:  W C Wolf; D M Evans; L Chao; J Chao
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

3.  Upregulation of bradykinin B1-receptor expression after myocardial infarction.

Authors:  C Tschöpe; S Heringer-Walther; M Koch; F Spillmann; M Wendorf; E Leitner; H P Schultheiss; T Walther
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

4.  B1 but not B2 bradykinin receptor agonists promote DU145 prostate cancer cell proliferation and migration.

Authors:  N Naidu; J H Botha; S Naidoo
Journal:  Afr Health Sci       Date:  2014-09       Impact factor: 0.927

5.  Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement.

Authors:  A Del Rosso; O Distler; A F Milia; C Emanueli; L Ibba-Manneschi; S Guiducci; M L Conforti; S Generini; A Pignone; S Gay; P Madeddu; M Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

6.  Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma.

Authors:  Kazuyuki Hirooka; Fumio Shiraga
Journal:  Clin Ophthalmol       Date:  2007-09

7.  Predisposition to atherosclerosis and aortic aneurysms in mice deficient in kinin B1 receptor and apolipoprotein E.

Authors:  Vanessa F Merino; Mihail Todiras; Marcelo A Mori; Vicência M T Sales; Raphael G Fonseca; Vera Saul; Katja Tenner; Michael Bader; João B Pesquero
Journal:  J Mol Med (Berl)       Date:  2009-07-18       Impact factor: 4.599

8.  Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway.

Authors:  Yu-Yu Yao; Hang Yin; Bo Shen; Robert S Smith; Yuying Liu; Lin Gao; Lee Chao; Julie Chao
Journal:  Cardiovasc Res       Date:  2008-08-09       Impact factor: 10.787

9.  Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage.

Authors:  G Gao; C Shao; S X Zhang; A Dudley; J Fant; J-X Ma
Journal:  Diabetologia       Date:  2003-05-13       Impact factor: 10.122

10.  Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential.

Authors:  Nicolle Kränkel; Rajesh G Katare; Mauro Siragusa; Luciola S Barcelos; Paola Campagnolo; Giuseppe Mangialardi; Orazio Fortunato; Gaia Spinetti; Nguyen Tran; Kai Zacharowski; Wojciech Wojakowski; Iwona Mroz; Andrew Herman; Jocelyn E Manning Fox; Patrick E MacDonald; Joost P Schanstra; Jean Loup Bascands; Raimondo Ascione; Gianni Angelini; Costanza Emanueli; Paolo Madeddu
Journal:  Circ Res       Date:  2008-10-16       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.